SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-257204
Filing Date
2024-11-13
Accepted
2024-11-13 16:09:56
Documents
1
Group Members
BRIAN TAYLOR SLINGSBYCATALYS PACIFIC FUND GP, LPCATALYS PACIFIC, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d847797dsc13ga.htm SC 13G/A 91272
  Complete submission text file 0001193125-24-257204.txt   93092
Mailing Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035
Business Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035 81 90-3536-3820
Catalys Pacific Fund, LP (Filed by) CIK: 0001746274 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94000 | Film No.: 241454237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)